Doctor profile · Federal record
Dr. Kevin Veverka, M.D.
Dermatology Physician (CMS: Dermatology) · Alcoa, TN
- NPI 1831694827
- Accepts Medicare
- MIPS 79.3 / 100 · 2023
- 8 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
232 Associates Blvd
Alcoa, TN 377011943
(865) 238-6450
fax (865) 238-6451 - Mailing address
-
300 E McBee Ave Fl 4
Greenville, SC 296012842
Credentials & registration
- NPI registered
- March 2018 — 8 yrs on file
- Profile last updated
- November 3, 2025
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Tennessee #64806
- Medicaid
- TN #Q076648
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831694827. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,140
Distinct HCPCS
10
Medicare allowed
$141,006
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 663 | 143 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 343 | 250 | $83 | |
17000 |
Destruction of precancer skin growth, 1 growth | 223 | 183 | $47 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 165 | 165 | $102 | |
11102 |
Biopsy of related skin growth, first growth | 163 | 138 | $86 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 158 | 115 | $118 | |
17110 |
Destruction of skin growth, 1-14 growths | 127 | 114 | $102 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 98 | 98 | $152 | |
11103 |
Biopsy of related skin growth, each additional growth | 45 | 32 | $46 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | 12 | $1 |
In context: peer comparison
Among 2 peers in Alcoa Dermatology Physician, average services per provider: 140. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$2,359
Transactions
116
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | 10 | $273.09 | |
| Novartis Pharmaceuticals Corporation | 12 | $268.58 | |
| Sun Pharmaceutical Industries INC. | 10 | $268.35 | |
| Abbvie INC. | 17 | $250.47 | |
| Dermavant Sciences, INC. | 10 | $187.02 | |
| Lilly USA, LLC | 13 | $169.34 | |
| Amgen INC. | 9 | $168.46 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $142.22 | |
| Ucb, INC. | 7 | $138.26 | |
| Incyte Corporation | 6 | $134.07 | |
| Almirall LLC | 4 | $89.63 | |
| Pfizer INC. | 5 | $81.63 | |
| Janssen Biotech, INC. | 4 | $78.22 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | 1 | $26.53 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $26.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
858
Patients
475
Total drug cost
$28,379
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 164 | 112 | $1,733 |
| Ketoconazole | Generic | 130 | 63 | $3,853 |
| Mupirocin | Generic | 111 | 81 | $1,071 |
| Clobetasol Propionate | Generic | 82 | 45 | $3,071 |
| Betamethasone Dipropionate | Generic | 71 | 47 | $3,469 |
| Doxycycline Hyclate | Generic | 67 | 31 | $3,450 |
| Fluorouracil | Generic | 45 | 41 | $4,965 |
| Prednisone | Generic | 42 | 0 | $301 |
| Hydrocortisone | Generic | 41 | 32 | $240 |
| Methotrexate (Methotrexate Sodium) | Brand | 22 | 0 | $480 |
Frequently asked questions
What is Dr. Kevin Veverka's medical specialty?
Dr. Kevin Veverka practices Dermatology Physician in Alcoa, TN.
Where does Dr. Kevin Veverka practice?
Dr. Kevin Veverka practices at 232 Associates Blvd, Alcoa, TN 377011943. Office phone: 8652386450.
What is Dr. Kevin Veverka's NPI?
Dr. Kevin Veverka's National Provider Identifier (NPI) is 1831694827, issued by NPPES.
Does Dr. Kevin Veverka accept Medicare assignment?
Yes. Dr. Kevin Veverka accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kevin Veverka commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.